A2AR ligands have been investigated in neurodegenerative diseases, such as Huntington’s disease (HD), Alzheimer’s disease (AD) and Parkinson’s disease (PD) [7,18,19,20]. This evidence concerns the gene ADORA2A and Parkinson disease.